We have observed
7 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after November 16, 2014).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Modified porcine somatotropin polypeptides and their uses
Modified bovine somatotropin polypeptides and their uses
HYDROGEN ABSORPTION ALLOY POWDER, NEGATIVE ELECTRODE, AND NICKEL-HYDROGEN SECONDARY CELL
METHOD FOR PREPARING AQUEOUS MANO PARTICLE SUSPENSIONS OF DERIVATIVES OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURAN ALIPHATIC ACID ESTERS
CARBON FIBER BUNDLE AND PROCESS FOR PRODUCING SAME
METHODS FOR PREPARING SAMPLES FOR NUCLEIC ACID AMPLIFICATION
SYNTHESIS OF SEMICONDUCTOR NANOPARTICLES USING METAL PRECURSORS COMPRISING NON- OR WEAKLY COORDINATING ANIONS